GlobeNewswire

Corvil Launches User-Centric Network Traffic Analysis For Accelerated Insider Threat Detection and Response

Dela

Solution automatically provides Security Analysts with a unified view of user identity, host and network activity in one system

DUBLIN, Ireland, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Corvil today announced the new release of its Security Analytics solution, which helps organizations identify malicious behavior from compromised user accounts that increase the risk of data theft and reputational damage.

With the coming introduction of regulations such as General Data Protection Regulation (GDPR), it is imperative that users and their data are protected by organizations. GDPR mandates notification of a data breach within seventy-two hours. Therefore, the ability to quickly detect abnormal user behavior, network access patterns and data exfiltration is essential.

Addressing these challenges, Corvil now provides unified, granular visibility and insight to activity across users, hosts, applications, and services.  By presenting a prioritized list of the most suspicious users in the environment as well as activity across associated devices of all types, security teams can rapidly see, understand and act on evasive threats and protect high-value assets.  

"In today's world, responding to insider threats depends on gaining comprehensive understanding of user activities across traditional IT domains - endpoints, networks, perimeters. Corvil's ability to provide comprehensive user activity insights into the security ecosystem represents a major step forward," said David Monahan, Managing Research Director, Security and Risk Management, Enterprise Management Associates, Inc.

The Corvil solution captures and analyzes L2-L7 network activity in real-time, contextually enriches with user identity and other data and automatically detects patterns of attack. Through streamlined workflows and intelligence sharing with the broader Security and Network Operations ecosystem (including SIEMs, Endpoint Detection and Response, Threat Intelligence, Next Generation Firewalls, and many big data systems), Security Teams can more effectively and efficiently combat threats in today's complex environments.  

With a single click, an analyst can quickly triage, forensically investigate and respond to incidents such as insider threats, evasive attack movements and ransomware attacks.  By providing linkage to the granular underlying communications, Security Teams can more quickly and with confidence, detect, identify the source, and determine the impact of breaches - live and retrospectively.

This solution is complemented by the machine learning-driven virtual security expert, Cara, released last year and deployed at some of the largest financial institutions in the world, to autonomously identify vulnerabilities and attacks in electronic financial transaction environments.  While Cara's daily cybersecurity intelligence report includes a cyber risk assessment score consumable by c-level executives, Corvil Security Analytics provides the additional granular, forensic record of user and host activity to help support compliance with emerging cybersecurity and data privacy regulations such as GDPR.

"Organizations today face unprecedented risk from cyber-attack and data loss," says Graham Ahearne, Director, Security Product Management. "As the automation and sophistication of attacks increases, all too often compromised user accounts, attacker footholds within the environment, and careless or malicious insiders are the elusive source.  Our new user-centric analytics provide security analysts with a unified view of all user activity on the host and on the network combined with automated risk-scoring, and actionable intelligence to accelerate detection, triage and response."

Security incidents expose organizations to reputational damage, legal and compliance exposure, and financial losses.  With more than 80 percent of breaches[1] stemming from inadvertent or malicious insiders, and with increasingly complex dynamic technology environments, organizations face new and growing threats every day. The faster an organization can identify and contain a data breach, the lower the costs.  However with a growing and diverse range of connected devices coupled with increasingly sophisticated and evasive attacks, it can take as long as five months[2] to detect a breach.  

Compounding matters, today's Security teams face shallow visibility and manual workflows often across fragmented systems while attempting to respond to a barrage of alerts.  While many technologies focus solely on a host-centric view of activity, attackers increasingly gain access through compromised user accounts, escalated privileges and covert communications that are undetectable without closer, more comprehensive analysis.

To learn more about Monitoring User Activity Across Network For Threat Detection and Response see details of our 2018 Corvil and Forrester Webinar.

Corvil's new Security Analytics release is generally available now.  For more information, or to contact a Corvil representative, please visit corvil.com.

About Corvil
Corvil is the industry leader for deriving Security, Operational, and Business intelligence from network data. As companies adopt faster and smarter machine technology, it becomes critical to tap into richer and more granular machine data sources to safeguard the transparency, performance and security of critical infrastructure and business applications. The Corvil streaming analytics platform captures, decodes, and learns from network data on the fly, transforming it into machine-time intelligence for network, IT, security and business teams to operate efficiently and securely in this new machine world. Corvil uses an open architecture to integrate the power of its network data analytics with the overall IT ecosystem providing increased automation and greater operational and business value outcomes for its users. The Corvil solution is trusted by leading financial institutions to safeguard their businesses across the globe involving 354 trillion messages with a daily transaction value in excess of $1 trillion.

Learn more about Corvil: Corvil.com | Twitter | LinkedIn 

Notes to the editor

[1] 81% of hacking-related breaches leveraged either stolen and/or weak passwords - 2017 Verizon DBIR. This means that 81% of attacks will come from hacker controlled machines inside the perimeter.
[2] Mean time to detect -
http://info.resilientsystems.com/hubfs/IBM_Resilient_Branded
_Content/White_Papers/2017_Global_CODB_Report_Final.pdf

Contact information: 
Press Office at Corvil
+353 1 859 1040
pressoffice@corvil.com 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Corvil via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum